ANAVEX LIFE SCIENCES CORP. Long-Term Debt
ANAVEX LIFE SCIENCES CORP. (AVXL) had Long-Term Debt of $345 as of 2016-06-30, per its 10-Q filed 2016-08-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2016-12-14
- 2016-06-30: Long-term Debt, Excluding Current Maturities $345.00.
- 2016-03-31: Long-term Debt, Excluding Current Maturities $337.00.
- 2015-12-31: Long-term Debt, Excluding Current Maturities $265.00.
- 2015-09-30: Long-term Debt, Excluding Current Maturities $332.00.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2016-06-30 | $345.00 10-Q · filed 2016-08-11 |
| 2016-03-31 | $337.00 10-Q · filed 2016-05-11 |
| 2015-12-31 | $265.00 10-Q · filed 2016-02-08 |
| 2015-09-30 | $332.00 10-K · filed 2016-12-14 |
| 2014-09-30 | $5.72M 10-K · filed 2015-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |